Tech Company M&A Transactions

Actagene Oncology Acquisition

On 5/21/2013, Actagene Oncology was bought by Ignyta. No transaction price was released.

Transaction Overview

Company Name
Acquired By
Announced On
5/21/2013
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed by the parties.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 92121
USA
Website
Email Address
Not Recorded
Overview
Actagene is developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing.
Profile
Actagene Oncology LinkedIn Company Profile
Social Media
Actagene Oncology Company Twitter Account
Company News
Actagene Oncology News
Facebook
Actagene Oncology on Facebook
YouTube
Actagene Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick O'Connor
  Patrick O'Connor LinkedIn Profile  Patrick O'Connor Twitter Account  Patrick O'Connor News  Patrick O'Connor on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/21/2013: Minbox venture capital transaction
Next: 5/21/2013: Swipely venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary